Status: Not yet recruiting
A Study to Evaluate the Safety and Effectiveness of Kytogen Defend in Facial Skin Quality Improvement in Adult Participants
This study was designed to evaluate the efficacy and safety of KIO021, an injectable solution for carboxymethyl chitosan, for temporary improvement of facial skin condition. Designed for forward-looking effectiveness. To achieve this, it is planned that 500 subjects with dry skin and dull complexion on the face will be included in the injection.
Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Sinclair Pharmaceuticals LimitedUpdated: Sep 17, 2025
Eligibility criteria
(1) Subjects ≥18 years (subject to the time of signing the ICF), without any res...
(1) Subjects who have known allergies to Carboxymethyl Chitosan Solutions or any...